Analyst Consensus ?
ConsensusBuy52 ratings
Bullish4280.8%
Neutral815.4%
Bearish23.8%
FN2 Earnings Intelligence
DexCom, Inc. complete analyst coverage
DexCom, Inc. (DXCM) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$74.13Current
$28.12Low
$75.98Average
$146High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Buy | Buy | Maintain | Jul 16, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 15, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Jun 23, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jun 15, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jun 10, 2026 |
| Stifel | Buy | Buy | Maintain | Jun 5, 2026 |
| Citigroup | Buy | Buy | Maintain | May 28, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | May 18, 2026 |
| Barclays | Underweight | Underweight | Maintain | May 18, 2026 |
| B of A Securities | Buy | Buy | Maintain | May 18, 2026 |
| BTIG | Buy | Buy | Maintain | Mar 9, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 13, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jan 9, 2026 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Dec 2, 2025 |
| Argus Research | Buy | Buy | Maintain | Nov 7, 2025 |
| UBS | Buy | Buy | Maintain | Nov 3, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 31, 2025 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 31, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 1, 2025 |
| Baird | Outperform | Outperform | Maintain | Sep 26, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 31, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 31, 2025 |
| Redburn Atlantic | Buy | Neutral | Upgrade | Feb 3, 2025 |
| Leerink Partners | Outperform | Outperform | Maintain | Oct 25, 2024 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 10, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Apr 29, 2022 |
| Guggenheim | Buy | Neutral | Upgrade | Jan 7, 2022 |
| Stephens & Co. | Overweight | Overweight | Maintain | Mar 26, 2020 |
| CFRA | Hold | Hold | Maintain | Feb 14, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Nov 7, 2019 |
| Piper Jaffray | Overweight | Overweight | Maintain | Nov 7, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Sep 3, 2019 |
| Bank of America | Buy | Buy | Maintain | Aug 1, 2019 |
| Northland Securities | Market Perform | Underperform | Upgrade | Sep 12, 2018 |
| Northland Capital Markets | Market Perform | Underperform | Upgrade | Sep 12, 2018 |
| Berenberg | Buy | Hold | Upgrade | Aug 6, 2018 |
| Jefferies | Buy | Buy | Maintain | Aug 2, 2018 |
| B. Riley FBR | Buy | Neutral | Upgrade | May 5, 2018 |
| BTIG Research | Neutral | Buy | Downgrade | May 3, 2017 |
| B. Riley Securities | Buy | Neutral | Upgrade | Dec 15, 2016 |
| Desjardins | Buy | Hold | Upgrade | Sep 16, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Oct 15, 2015 |
| Sterne Agee | Buy | Neutral | Upgrade | Oct 15, 2015 |
| Leerink Swann | Outperform | Market Perform | Upgrade | Oct 15, 2015 |
| Feltl & Co. | Sell | Hold | Downgrade | Feb 20, 2014 |
| Wedbush | Outperform | Outperform | Maintain | Nov 7, 2013 |
| Benchmark | Buy | Buy | Maintain | Nov 7, 2013 |
| Wunderlich Securities | Hold | Buy | Downgrade | Jun 10, 2013 |
| Wunderlich | Hold | Buy | Downgrade | Jun 10, 2013 |
| PiperJaffray | Overweight | Overweight | Maintain | Sep 20, 2012 |
| McNicoll Lewis Vlak | Hold | Hold | Maintain | May 3, 2012 |
| Brean Capital | Buy | Buy | Maintain | Feb 24, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $74.13. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $96 | $73.37 | +29.5% | Jul 28, 2026 |
| Truist Financial | Analyst unavailable | $87 | $77.61 | +17.4% | Jul 16, 2026 |
| Deutsche Bank | Analyst unavailable | $86 | $69.07 | +16.0% | Jun 23, 2026 |
| Piper Sandler | Matt O'Brien | $88 | $75.37 | +18.7% | Jun 15, 2026 |
| UBS | Analyst unavailable | $95 | $78.42 | +28.2% | Jun 10, 2026 |
| Mizuho Securities | Anthony Petrone | $85 | $76.62 | +14.7% | Jun 9, 2026 |
| Raymond James | Analyst unavailable | $91 | $76.62 | +22.8% | Jun 8, 2026 |
| Stifel Nicolaus | Jonathan Block | $90 | $72.59 | +21.4% | Jun 5, 2026 |
| Canaccord Genuity | Analyst unavailable | $82 | $61.63 | +10.6% | May 18, 2026 |
| Barclays | Matt Miksic | $64 | $61.63 | -13.7% | May 18, 2026 |
| Bernstein | Analyst unavailable | $77 | $61.03 | +3.9% | May 1, 2026 |
| Robert W. Baird | Analyst unavailable | $80 | $61.82 | +7.9% | May 1, 2026 |
| Mizuho Securities | Anthony Petrone | $75 | $61.65 | +1.2% | May 1, 2026 |
| Raymond James | Analyst unavailable | $81 | $59.55 | +9.3% | May 1, 2026 |
| Canaccord Genuity | Analyst unavailable | $100 | $59.55 | +34.9% | May 1, 2026 |
| Barclays | Analyst unavailable | $67 | $59.55 | -9.6% | May 1, 2026 |
| Robert W. Baird | Analyst unavailable | $87 | $70.67 | +17.4% | Feb 13, 2026 |
| Mizuho Securities | Anthony Petrone | $90 | $65.08 | +21.4% | Feb 13, 2026 |
| Canaccord Genuity | Analyst unavailable | $95 | $65.08 | +28.2% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $72 | $65.08 | -2.9% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $71 | $69.67 | -4.2% | Jan 12, 2026 |
| Bernstein | Analyst unavailable | $86 | $68.43 | +16.0% | Jan 9, 2026 |
| Mizuho Securities | Analyst unavailable | $78 | $66.37 | +5.2% | Dec 17, 2025 |
| Leerink Partners | Mike Kratky | $92 | $65.38 | +24.1% | Dec 16, 2025 |
| Morgan Stanley | Patrick Wood | $75 | $63.52 | +1.2% | Dec 2, 2025 |
| Morgan Stanley | Analyst unavailable | $63 | $55.21 | -15.0% | Nov 10, 2025 |
| Bernstein | Lee Hambright | $84 | $58.22 | +13.3% | Nov 3, 2025 |
| Barclays | Analyst unavailable | $80 | $58.22 | +7.9% | Nov 3, 2025 |
| Piper Sandler | Matt O'Brien | $75 | $56.97 | +1.2% | Oct 31, 2025 |
| RBC Capital | Analyst unavailable | $85 | $56.95 | +14.7% | Oct 31, 2025 |
| Robert W. Baird | Analyst unavailable | $82 | $59.19 | +10.6% | Oct 31, 2025 |
| Wells Fargo | Analyst unavailable | $93 | $68.2 | +25.5% | Oct 31, 2025 |
| Canaccord Genuity | William Plovanic | $99 | $68.2 | +33.5% | Oct 31, 2025 |
| Piper Sandler | Matt O'Brien | $100 | $68.44 | +34.9% | Oct 21, 2025 |
| Truist Financial | Richard Newitter | $94 | $65.55 | +26.8% | Oct 15, 2025 |
| Robert W. Baird | Analyst unavailable | $90 | $68.3 | +21.4% | Sep 26, 2025 |
| RBC Capital | Shagun Singh | $120 | $68.62 | +61.9% | Oct 8, 2024 |
| Stifel Nicolaus | Mathew Blackman | $100 | $72.28 | +34.9% | Aug 22, 2024 |
| RBC Capital | Shagun Singh | $130 | $72.36 | +75.4% | Aug 16, 2024 |
| Barclays | Matt Miksic | $113 | $64 | +52.4% | Jul 29, 2024 |
| Oppenheimer | Steven Lichtman | $115 | $107.85 | +55.1% | Jul 26, 2024 |
| Piper Sandler | Matt O\'Brien | $90 | $63.22 | +21.4% | Jul 26, 2024 |
| Canaccord Genuity | William Plovanic | $89 | $107.85 | +20.1% | Jul 26, 2024 |
| RBC Capital | Shagun Singh | $72.5 | $31.77 | -2.2% | Jul 26, 2024 |
| Stifel Nicolaus | Mathew Blackman | $132 | $112.66 | +78.1% | Jul 12, 2024 |
| Oppenheimer | Steven Lichtman | $150 | $115.23 | +102.3% | Jun 3, 2024 |
| Redburn Partners | Issie Kirby | $130 | $127.64 | +75.4% | May 30, 2024 |
| RBC Capital | Shagun Singh | $165 | $134.48 | +122.6% | Mar 12, 2024 |
| Oppenheimer | Steven Lichtman | $122 | $88.91 | +64.6% | Oct 27, 2023 |
| Morgan Stanley | Analyst unavailable | $131 | $114.45 | +76.7% | Jan 6, 2023 |
| Stifel Nicolaus | Stifel Stifel | $130 | $111.44 | +75.4% | Dec 26, 2022 |
| Citigroup | Analyst unavailable | $146 | $116.64 | +97.0% | Dec 12, 2022 |
| Piper Sandler | Matt O'Brien | $120 | $95.21 | +61.9% | Oct 7, 2022 |
| Raymond James | Analyst unavailable | $101 | $82.08 | +36.2% | Aug 1, 2022 |
| Morgan Stanley | Analyst unavailable | $83 | $86.99 | +12.0% | Jul 29, 2022 |
| Piper Sandler | Matt O'Brien | $110 | $86.99 | +48.4% | Jul 28, 2022 |
| Bernstein | Lee Hambright | $105 | $76.5 | +41.6% | Jul 15, 2022 |
| BTIG | Marie Thibault | $105 | $76.6 | +41.6% | Jun 28, 2022 |
| Morgan Stanley | Analyst unavailable | $91 | $69.31 | +22.8% | Jun 15, 2022 |
| Morgan Stanley | Analyst unavailable | $90.75 | $70.74 | +22.4% | Jun 13, 2022 |
| Morgan Stanley | Analyst unavailable | $22.69 | $19.28 | -69.4% | Jun 7, 2022 |
| Leerink Partners | Danielle Antalffy | $31.25 | $24.79 | -57.8% | May 3, 2022 |
| Raymond James | Analyst unavailable | $30.38 | $26.05 | -59.0% | Apr 29, 2022 |
| Piper Sandler | Analyst unavailable | $30 | $25.83 | -59.5% | Apr 29, 2022 |
| BTIG | Marie Thibault | $35 | $31.02 | -52.8% | Apr 21, 2022 |
| Bank of America Securities | Travis Steed | $31.25 | $26.5 | -57.8% | Mar 3, 2022 |
| Citigroup | Joanna Wuensch | $39.38 | $26.28 | -46.9% | Feb 11, 2022 |
| Oppenheimer | Steven Lichtman | $36.25 | $26.9 | -51.1% | Jan 31, 2022 |
| Wells Fargo | Larry Biegelsen | $35.94 | $27.2 | -51.5% | Jan 19, 2022 |
| Raymond James | Jayson Bedford | $33.62 | $27.2 | -54.6% | Jan 19, 2022 |
| Canaccord Genuity | Kyle Rose | $39.06 | $38.95 | -47.3% | Oct 29, 2021 |
| Berenberg Bank | Ravi Misra | $39.38 | $38.95 | -46.9% | Oct 29, 2021 |
| UBS | Matthew Taylor | $41.25 | $38.95 | -44.4% | Oct 29, 2021 |
| Jefferies | Anthony Petrone | $40.94 | $38.95 | -44.8% | Oct 29, 2021 |
| Stephens | Chris Cooley | $34.12 | $32.22 | -54.0% | Jul 30, 2021 |
| J.P. Morgan | Robbie Marcus | $28.12 | $24.38 | -62.1% | Jun 9, 2021 |
Track every rating change on DXCM the moment it posts. Free to start.
Start free